Annexon

Annexon FCF/Debt

The Free Cash Flow to Debt Ratio of Annexon (ANNX) as of Oct 16, 2026 is -6,413.10 %.

FCF/Debt

-6,413.10 %

Last updated:

Free Cash Flow to Debt Ratio of Annexon is 2025 -6,413.10 % . Free Cash Flow to Debt Ratio of Annexon was 2024 - . It decreases by % lower compared to the previous year.

The Annexon FCF/Debt history

The Annexon FCF/Debt history
YEARFCF/DebtYoY
-6,413.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Annexon Stock analysis

What does Annexon do? Annexon Inc is a biopharmaceutical company based in South San Francisco, California. It was founded in 2011 by Doug Love, Ted Love, and Arnon Rosenthal, who had previously worked at major pharmaceutical companies such as Genentech and Novartis. The company's main goal is to develop new treatment options for neurodegenerative diseases, focusing on the development of drugs that target the autophagy process in cells to reduce damage to nerve cells and alleviate symptoms. Annexon Inc has two divisions, Annexon Biosciences and Annexon Clinical, with partnerships with renowned pharmaceutical companies to advance drug development. Its main product is ANX005, a therapeutic antibody protein that targets the role of the complement system in neurodegenerative diseases. Annexon Inc has received multiple awards for its work and innovations and has a dedicated team of scientists and executives committed to improving the lives of people with neurodegenerative diseases. Annexon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Annexon stock

Free Cash Flow to Debt Ratio of Annexon is -6,413.10 % in 2025.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Annexon since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Annexon with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Annexon

All Key Metrics — Annexon